Trehaloza kao potencijalni terapeutski agens u različitim bolestima

Danijela Stevanović; Ljubica  Vučićević; Vladimir Trajković

doi:10.5937/mp74-41378

Danijela Stevanović Medicinski fakultet, Univerziteta u Beogradu, Beograd https://orcid.org/0000-0002-3788-7130
Ljubica Vučićević Institut za biološka istraživanja „Siniša Stanković" Institut od nacionalnog značaja za Republiku Srbiju, Univerzitet u Beogradu https://orcid.org/0000-0003-2802-2773
Vladimir Trajković Medicinski fakultet, Univerziteta u Beogradu, Beograd https://orcid.org/0000-0002-8061-2968

DOI: https://doi.org/10.5937/mp74-41378

Keywords: trehalose, oxidative stess, autophagy, therapy

Abstract

Trehalose is a natural non-reducing disaccharide synthesized in some bacteria, fungi, plants and insects. Due to its favorable physical and chemical properties, trehalose can replace water and stabilize macromolecules, thus protecting cells from drying out, heating and freezing. Vertebrates do not synthesize trehalose, but the beneficial effects of trehalose have been demonstrated in many diseases due to its ability to eliminate aggregates and damaged organelles, as well as to reduce hyperinflammation and oxidative stress. Trehalose induces autophagy by nuclear translocation and activation of transcriptional factor EB (TFEB) in mTOR-independent manner, but it enhances SQSTM1/p62 expression and exibits antioxidative properties in an autophagy-independent manner. Additionally, by increasing membrane fluidity, trehalose induces apoptosis in tumor cells, through the activation of caspase 3, 6 and JNK (c-Jun N-terminal kinase) signaling pathway. Taken together, in this review we summarized previous knowledge about the therapeutic potential of trehalose in different diseases such as dry eye syndrome, neurodegenerative diseases and tumors, with special reference to its underlying molecular mechanisms.

Author Biographies

Danijela Stevanović, Medicinski fakultet, Univerziteta u Beogradu, Beograd

Danijela Stevanović, MD, Research Assistant

Ljubica Vučićević, Institut za biološka istraživanja „Siniša Stanković" Institut od nacionalnog značaja za Republiku Srbiju, Univerzitet u Beogradu

Ljubica Vučićević, Senior Research Associate, Department of neurophysiology (IBISS), Belgrade

Vladimir Trajković, Medicinski fakultet, Univerziteta u Beogradu, Beograd

Vladimir Trajković, MD, PhD, Proffesor (full), Institute of microbiology and immunology, School of Medicine University of Belgrade

References

1. Teramoto N, Sachinvala ND, Shibata M. Trehalose and trehalose-based polymers for environmentally benign, biocompatible and bioactive materials. Molecules. 2008 Aug;13(8):1773-816.

2. Penna S. Building stress tolerance through over-producing trehalose in transgenic plants. Trends Plant Sci. 2003 Aug;8(8):355-7.

3. Liu J, Chen C, Lu C, Li W. Different mechanisms on the stabilization of POPC membrane by trehalose upon varied mechanical stress. Journal of Molecular Liquids. 2019 Feb;275:839-48.

4. Tapia H, Young L, Fox D, Bertozzi CR, Koshland D. Increasing intracellular trehalose is sufficient to confer desiccation tolerance to Saccharomyces cerevisiae. Proceedings of the National Academy of Sciences. 2015 Apr;112(19):6122-7.

5. Tapia H, Koshland DE. Trehalose is a versatile and long-lived chaperone for desiccation tolerance. Current Biology. 2014 Dec;24(23):2758-66.

6. Krüger U, Wang Y, Kumar S, Mandelkow EM. Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiology of aging. 2012 Oct;33(10):2291-305.

7. Tanaka M, Machida Y, Niu S, Ikeda T, Jana NR, Doi H, et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nature medicine. 2004 Jan;10(2):148-54.

8. Zhang X, Chen S, Song L, Tang Y, Shen Y, Jia L, et al. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Autophagy. 2014 Apr;10(4):588-602.

9. Liu, Z, Chen D, Chen X, Bian F, Qin W, Gao N, et al. Trehalose Induces Autophagy Against Inflammation by Activating TFEB Signaling Pathway in Human Corneal Epithelial Cells Exposed to Hyperosmotic Stress. Investigative Ophthalmology & Visual Science. 2020 Aug;61(10):26.

10. Matsumoto Y, Cao E, Ueoka R. Hybrid liposomes composed of dimyristoylphosphatidylcholine and trehalose surfactants inhibit the growth of tumor cells along with apoptosis. Biological and Pharmaceutical Bulletin. 2013 Aug:b13-00266.

11. Matsumoto Y, Kuwabara K, Ichihara H, Kuwano M. Therapeutic effects of trehalose liposomes against lymphoblastic leukemia leading to apoptosis in vitro and in vivo. Bioorganic & medicinal chemistry letters. 2016 Jan;26(2):301-5.

12. Ichihara H, Kuwabara K, Matsumoto Y. Trehalose liposomes suppress the growth of tumors on human lung carcinoma-bearing mice by induction of apoptosis in vivo. Anticancer research. 2017 Nov;37(11):6133-9.

13. Kuwabara K, Matsumoto Y. Trehalose liposomes induce apoptosis of breast tumor cells in vitro and in vivo. Biochemical and Biophysical Research Communications. 2020 Nov;532(4):505-12.

14. Allavena G, Del Bello B, Tini P, Volpi N, Valacchi G, Miracco C, et al. Trehalose inhibits cell proliferation and amplifies long-term temozolomide- and radiation-induced cytotoxicity in melanoma cells: A role for autophagy and premature senescence. J Cell Physiol. 2019 Jul;234(7):11708-11721.

15. Jain NK, Roy I. Effect of trehalose on protein structure. Protein Sci. 2009 Jan;18(1):24-36.

16. Rusmini P, Cortese K, Crippa V, Cristofani R, Cicardi ME, Ferrari V, et al. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. Autophagy. 2019 Apr;15(4):631-651.

17. Avonce N, Mendoza-Vargas A, Morett E, Iturriaga G. Insights on the evolution of trehalose biosynthesis. BMC Evol Biol. 2006 Dec;6:109.

18. Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol. 2010 Apr;22(2):124-131.

19. Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol. 2009 Jul;10(7):458-67.

20. Alers S, Löffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol. 2012 Jan;32(1):2-11.

21. Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol. 2011 Jul;27:107-32.

22. Hosseinpour‐Moghaddam K, Caraglia M, Sahebkar A. Autophagy induction by trehalose: Molecular mechanisms and therapeutic impacts. Journal of cellular physiology. 2018 Sep;233(9):6524-43.

23. Lee HJ, Yoon YS, Lee SJ. Mechanism of neuroprotection by trehalose: controversy surrounding autophagy induction. Cell Death Dis. 2018 Jun;9(7):712.

24. Rusmini P, Crippa V, Giorgetti E, Boncoraglio A, Cristofani R, Carra S, et al. Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy. Neurobiol Aging. 2013 Nov;34(11):2585-603.

25. Mardones P, Rubinsztein DC, Hetz C. Mystery solved: Trehalose kickstarts autophagy by blocking glucose transport. Sci Signal. 2016 Feb;9(416):fs2.

26. Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem. 2007 Feb;282(8):5641-52.

27. Mizunoe Y, Kobayashi M, Sudo Y, Watanabe S, Yasukawa H, Natori D, et al. Trehalose protects against oxidative stress by regulating the Keap1-Nrf2 and autophagy pathways. Redox Biol. 2018 May;15:115-124.

28. Gao Z, Wang H, Zhang B, Wu X, Zhang Y, Ge P, et al. Trehalose inhibits H₂O₂-induced autophagic death in dopaminergic SH-SY5Y cells via mitigation of ROS-dependent endoplasmic reticulum stress and AMPK activation. Int J Med Sci. 2018 Jun;15(10):1014-1024.

29. S N Chaitanya N, Devi A, Sahu S, Alugoju P. Molecular mechanisms of action of Trehalose in cancer: A comprehensive review. Life Sciences. 2021 Mar;269:118968.

30. Wu S, Lu H, Bai Y. Nrf2 in cancers: A double‐edged sword. Cancer medicine. 2019 May;8.5: 2252-2267.

31. Li Y, Hodge J, Liu Q, Wang J, Wang Y, Evans TD, et al. TFEB is a master regulator of tumor-associated macrophages in breast cancer. J Immunother Cancer. 2020 Jun;8(1):e000543.

32. Yun CW, Lee SH. The roles of autophagy in cancer. International journal of molecular sciences. 2018 Nov;19(11):3466.

33. Labetoulle M, Hernandez E, Haigh O, Rousseau A, Esclatine A. Up-regulating autophagy with trehalose: a contribution to osmoprotective properties?. Investigative Ophthalmology & Visual Science, 2019 July;60.9: 267-267

34. Khalifeh M, Barreto GE, Sahebkar A. Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease. British journal of pharmacology, 2019 May;176.9: 1173-1189.

35. Amin A, Perera ND, Beart PM, Turner BJ, Shabanpoor F. Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting. Cells. 2020 Nov;9(11):2413.

36. Li Y, Guo Y, Wang X, Yu X, Duan W, Hong K, et al. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model. Neuroscience. 2015 Jul;298:12-25.

37. Castillo K, Nassif M, Valenzuela V, Rojas F, Matus S, Mercado G, et al. Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy. 2013 Sep;9(9):1308-20.

38. Tanaka M, Machida Y, Niu S, Ikeda T, Jana NR, Doi H, et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nature medicine, 2004 Feb;10.2: 148-154.

39. Li Q, Liu Y, Sun M. Autophagy and Alzheimer's Disease. Cell Mol Neurobiol. 2017 Apr;37(3):377-388.

40. Khalifeh M, Read MI, Barreto GE, Sahebkar A. Trehalose against Alzheimer's Disease: Insights into a Potential Therapy. Bioessays. 2020 Aug;42(8):e1900195.

41. Boland B, Yu WH, Corti O, Mollereau B, Henriques A, Bezard E, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2018 Sep;17(9):660-688.

42. Krüger U, Wang Y, Kumar S, Mandelkow EM. Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol Aging. 2012 Oct;33(10):2291-305.

43. Rodríguez-Navarro JA, Rodríguez L, Casarejos MJ, Solano RM, Gómez A, Perucho J, et al. Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation. Neurobiol Dis. 2010 Sep;39(3):423-38.

44. Lan DM, Liu FT, Zhao J, Chen Y, Wu JJ, Ding ZT, et al. Effect of trehalose on PC12 cells overexpressing wild-type or A53T mutant α-synuclein. Neurochem Res. 2012 Sep;37(9):2025-32.

45. Tanji K, Miki Y, Maruyama A, Mimura J, Matsumiya T, Mori F, et al. Trehalose intake induces chaperone molecules along with autophagy in a mouse model of Lewy body disease. Biochem Biophys Res Commun. 2015 Oct;465(4):746-52.

46. Sarkar S, Chigurupati S, Raymick J, Mann D, Bowyer JF, Schmitt T, et al. Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model. Neurotoxicology. 2014 Sep;44250-62.

47. Holler CJ, Taylor G, McEachinm ZT, Deng Q, Watkins WJ, Hudson K, et al. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia. Molecular neurodegeneration, 2016 Jun;11.1: 1-17.